Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Drouin

Showing results (91-100 of 244) with videos related to

Pageof 25
Sort By:
Journees Annuelles De Diabetologie De L'Hotel-Dieu|January 1, 1984
[Nutrition and atherosclerosis]G Debry, P Drouin, J P Pointel, et al.
Gynecologic Oncology|February 1, 1990
Vaginal intraepithelial neoplasiaP Audet-Lapointe, G Body, R Vauclair, et al.
Diabetes Care|May 1, 1987
Factitious hypoglycemia mimicking insulinomaO Ziegler, P Gross, M Kolopp, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1984
[Morphometric study of hepatic peroxisomes in hyperlipoproteinemic patients treated with fenofibrate]P Gariot, J P Pointel, E Barrat, et al.
Angiology|March 1, 1981
Venous plethysmography: measuring techniques and normal valuesJ P Pointel, H Gin, P Drouin, et al.
Comptes Rendus Des Seances De La Societe De Biologie Et De Ses Filiales|January 1, 1974
[Distribution of the serum lipid levels in a population of healthy adults of both sexes between the ages of 20 and 30: correlation between these values]L Mejean, J M Mur, P Drouin, et al.
Diabetes & Metabolism|September 8, 2001
Endothelial dysfunction and type 2 diabetes. Part 2: altered endothelial function and the effects of treatments in type 2 diabetes mellitusB Guerci, P Böhme, A Kearney-Schwartz, et al.
Therapie|September 1, 1978
[Hypolipidemic effect of cholestyramine in patients affected by type II hyperlipoproteinemia]J P Sauvanet, P Drouin, L Mejean, et al.
Therapie|July 1, 1980
[Effect of colestipol on plasma lipids in patients affected by type Ii primary hyperlipoproteinaemia (author's transl)]P Drouin, J P Sauvanet, D Lambert, et al.
International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity|March 3, 1998
Efficacy and tolerability of sibutramine in obese patients: a dose-ranging studyC Hanotin, F Thomas, S P Jones, et al.
Pageof 25

Showing results (91-100 of 244) with videos related to

Sort By:
Pageof 25
Journees Annuelles De Diabetologie De L'Hotel-Dieu|January 1, 1984
[Nutrition and atherosclerosis]G Debry, P Drouin, J P Pointel, et al.
Gynecologic Oncology|February 1, 1990
Vaginal intraepithelial neoplasiaP Audet-Lapointe, G Body, R Vauclair, et al.
Diabetes Care|May 1, 1987
Factitious hypoglycemia mimicking insulinomaO Ziegler, P Gross, M Kolopp, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1984
[Morphometric study of hepatic peroxisomes in hyperlipoproteinemic patients treated with fenofibrate]P Gariot, J P Pointel, E Barrat, et al.
Angiology|March 1, 1981
Venous plethysmography: measuring techniques and normal valuesJ P Pointel, H Gin, P Drouin, et al.
Comptes Rendus Des Seances De La Societe De Biologie Et De Ses Filiales|January 1, 1974
[Distribution of the serum lipid levels in a population of healthy adults of both sexes between the ages of 20 and 30: correlation between these values]L Mejean, J M Mur, P Drouin, et al.
Diabetes & Metabolism|September 8, 2001
Endothelial dysfunction and type 2 diabetes. Part 2: altered endothelial function and the effects of treatments in type 2 diabetes mellitusB Guerci, P Böhme, A Kearney-Schwartz, et al.
Therapie|September 1, 1978
[Hypolipidemic effect of cholestyramine in patients affected by type II hyperlipoproteinemia]J P Sauvanet, P Drouin, L Mejean, et al.
Therapie|July 1, 1980
[Effect of colestipol on plasma lipids in patients affected by type Ii primary hyperlipoproteinaemia (author's transl)]P Drouin, J P Sauvanet, D Lambert, et al.
International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity|March 3, 1998
Efficacy and tolerability of sibutramine in obese patients: a dose-ranging studyC Hanotin, F Thomas, S P Jones, et al.
Pageof 25